Efficacy in Japanese adults with growth hormone deficiency receiving weekly somapacitan or daily growth hormone: results from phase 3 REAL 1 trial

Efficacy in Japanese adults with growth hormone deficiency receiving weekly somapacitan or daily growth hormone: results from phase 3 REAL 1 trial

IntroductionSomapacitan is a long-acting growth hormone (GH) derivative approved for once-weekly treatment of adult GH deficiency (AGHD). This study aimed to evaluate the efficacy and safety of somapacitan and daily GH in Japanese individuals with AGHD.MethodsThis subgroup study included the 34-week...

Full description

Saved in:
Bibliographic Details
Main Authors: Fumio Otsuka, Michael Højby Rasmussen, Takaaki Endo, Claus Sværke, Shigeyuki Tahara, Gudmundur Johannsson
Format: Article
Language:English
Published: Frontiers Media S.A. 2025-02-01
Series:Frontiers in Endocrinology
Subjects:
growth hormone
adult growth hormone deficiency
long-acting growth hormone
somapacitan
Japan
Online Access:https://www.frontiersin.org/articles/10.3389/fendo.2025.1534891/full
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items

Similar Items